EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) Receives Average Rating of “Moderate Buy” from Brokerages

EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) has been assigned an average recommendation of “Moderate Buy” from the nine research firms that are currently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, four have given a buy rating and two have given a strong buy rating to the company.

A number of research analysts recently commented on ESLOY shares. The Goldman Sachs Group downgraded EssilorLuxottica from a “buy” rating to a “hold” rating in a research note on Tuesday, July 14th. Zacks Research downgraded shares of EssilorLuxottica from a “hold” rating to a “strong sell” rating in a research note on Tuesday, June 23rd. Finally, Deutsche Bank Aktiengesellschaft initiated coverage on shares of EssilorLuxottica in a report on Tuesday, May 12th. They issued a “hold” rating on the stock.

EssilorLuxottica Stock Up 0.6%

OTCMKTS ESLOY opened at $95.14 on Friday. The company has a current ratio of 0.99, a quick ratio of 0.70 and a debt-to-equity ratio of 0.17. The company has a 50 day moving average of $98.30 and a 200-day moving average of $117.16. EssilorLuxottica has a 1-year low of $91.44 and a 1-year high of $186.81.

EssilorLuxottica Company Profile

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.